JP2011503032A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011503032A5 JP2011503032A5 JP2010532599A JP2010532599A JP2011503032A5 JP 2011503032 A5 JP2011503032 A5 JP 2011503032A5 JP 2010532599 A JP2010532599 A JP 2010532599A JP 2010532599 A JP2010532599 A JP 2010532599A JP 2011503032 A5 JP2011503032 A5 JP 2011503032A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dichlorophenyl
- alkyl
- carboxamide
- triazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0722075.9A GB0722075D0 (en) | 2007-11-09 | 2007-11-09 | Compounds |
| GB0722075.9 | 2007-11-09 | ||
| PCT/EP2008/065105 WO2009060054A1 (en) | 2007-11-09 | 2008-11-07 | Triazole derivatives as scd inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011503032A JP2011503032A (ja) | 2011-01-27 |
| JP2011503032A5 true JP2011503032A5 (enExample) | 2011-12-15 |
| JP5597542B2 JP5597542B2 (ja) | 2014-10-01 |
Family
ID=38858480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532599A Expired - Fee Related JP5597542B2 (ja) | 2007-11-09 | 2008-11-07 | Ｓｃｄ阻害薬としてのトリアゾール誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US8207204B2 (enExample) |
| EP (1) | EP2207774B1 (enExample) |
| JP (1) | JP5597542B2 (enExample) |
| ES (1) | ES2575955T3 (enExample) |
| GB (1) | GB0722075D0 (enExample) |
| WO (1) | WO2009060054A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0722075D0 (en) * | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
| GB0722077D0 (en) | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
| JP5748947B2 (ja) * | 2009-09-01 | 2015-07-15 | 公益財団法人相模中央化学研究所 | ２−アシルアミノチアゾール誘導体及びその製造方法 |
| WO2013134546A1 (en) | 2012-03-07 | 2013-09-12 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| CN102746853B (zh) * | 2012-06-18 | 2013-12-11 | 北京科技大学 | 一种三唑类弯曲棒状液晶化合物及其制备方法 |
| WO2014120994A1 (en) * | 2013-01-31 | 2014-08-07 | The Johns Hopkins University | Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels |
| GB201401886D0 (en) | 2014-02-04 | 2014-03-19 | Lytix Biopharma As | Neurodegenerative therapies |
| EP4180041A1 (en) | 2014-08-07 | 2023-05-17 | Mayo Foundation for Medical Education and Research | Compounds and methods for treating cancer |
| WO2016202935A1 (en) * | 2015-06-19 | 2016-12-22 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
| US10294237B2 (en) | 2015-06-22 | 2019-05-21 | Sumitomo Dainippon Pharma Co., Ltd. | Bicyclic heterocyclic amide derivative |
| CA2990583A1 (en) * | 2015-06-22 | 2016-12-29 | Sumitomo Dainippon Pharma Co., Ltd. | 1,4-disubstituted imidazole derivative |
| JP6896701B2 (ja) | 2016-02-26 | 2021-06-30 | 大日本住友製薬株式会社 | イミダゾリルアミド誘導体 |
| MA46589A (fr) | 2016-10-24 | 2019-08-28 | Yumanity Therapeutics Inc | Composés et utilisations de ces derniers |
| KR20190108118A (ko) | 2017-01-06 | 2019-09-23 | 유마니티 테라퓨틱스, 인크. | 신경계 장애의 치료를 위한 방법 |
| US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
| KR20190110740A (ko) | 2018-03-21 | 2019-10-01 | 주식회사유한양행 | 신규의 아릴 또는 헤테로아릴 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| KR20190110736A (ko) * | 2018-03-21 | 2019-10-01 | 주식회사유한양행 | 신규의 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| MX2020009942A (es) | 2018-03-23 | 2021-01-08 | Yumanity Therapeutics Inc | Compuestos y usos de los mismos. |
| TWI835945B (zh) | 2018-12-14 | 2024-03-21 | 南韓商柳韓洋行股份有限公司 | 3,3-二氟烯丙胺化物或其鹽及包含彼的醫藥組合物 |
| TW202039486A (zh) | 2018-12-14 | 2020-11-01 | 南韓商柳韓洋行股份有限公司 | 三唑并吡啶-3-酮化物或其鹽及包含彼之醫藥組合物 |
| KR20220007845A (ko) | 2019-01-24 | 2022-01-19 | 유마니티 테라퓨틱스, 인크. | 화합물 및 이의 용도 |
| EA202192047A1 (ru) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | Соединения и их применение |
| GB202205846D0 (en) * | 2022-04-22 | 2022-06-08 | Phytoquest Ltd | Bioactive molecules in yogurt |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060160794A1 (en) * | 2003-06-12 | 2006-07-20 | Amegadzie Albert K | Tachykinin receptor antagonists |
| WO2006101521A2 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| DE102005019970B4 (de) | 2005-04-27 | 2007-04-26 | Phoenix Contact Gmbh & Co. Kg | Adressvergabe für sichere Busteilnehmer |
| WO2007009236A1 (en) * | 2005-07-20 | 2007-01-25 | Merck Frosst Canada Ltd. | Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| GB0625605D0 (en) | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds |
| GB0625654D0 (en) | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds |
| GB0625594D0 (en) | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds |
| GB0625604D0 (en) | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds |
| EP2125799A1 (en) | 2007-02-28 | 2009-12-02 | Smithkline Beecham Corporation | Thiadiazole derivatives, inhibitors of stearoyl-coa desaturase |
| GB0714129D0 (en) | 2007-07-19 | 2007-08-29 | Smithkline Beecham Corp | compounds |
| GB0715055D0 (en) | 2007-08-02 | 2007-09-12 | Smithkline Beecham Corp | Compounds |
| GB0721419D0 (en) | 2007-10-31 | 2007-12-12 | Smithkline Beecham Corp | Compounds |
| GB0722077D0 (en) | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
| GB0722075D0 (en) * | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds |
| GB0810913D0 (en) | 2008-06-13 | 2008-07-23 | Smithkline Beecham Corp | Comppounds |
-
2007
- 2007-11-09 GB GBGB0722075.9A patent/GB0722075D0/en not_active Ceased
-
2008
- 2008-11-07 JP JP2010532599A patent/JP5597542B2/ja not_active Expired - Fee Related
- 2008-11-07 EP EP08847760.9A patent/EP2207774B1/en not_active Not-in-force
- 2008-11-07 US US12/741,629 patent/US8207204B2/en not_active Expired - Fee Related
- 2008-11-07 WO PCT/EP2008/065105 patent/WO2009060054A1/en not_active Ceased
- 2008-11-07 ES ES08847760.9T patent/ES2575955T3/es active Active
-
2012
- 2012-05-15 US US13/471,731 patent/US20120225878A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011503032A5 (enExample) | ||
| ES2575955T3 (es) | Derivados de triazol como inhibidores de SCD | |
| JP5115474B2 (ja) | 消化管潰瘍治療又は予防薬 | |
| RU2461551C2 (ru) | Азолкарбоксамидное соединение или его фармацевтически приемлемая соль | |
| RU2447060C2 (ru) | Ингибиторы сфингозинкиназы | |
| JP2007536224A5 (enExample) | ||
| EP2592073B1 (en) | Human protein tyrosine phosphatase inhibitors and their use | |
| JP2019077725A5 (enExample) | ||
| RU2439068C2 (ru) | Модуляторы mglur5 | |
| RU2501791C2 (ru) | Производное триазола или его соль | |
| HRP20140346T1 (hr) | DERIVATI 1,2,3-TRIAZOLA, NAMIJENJENI UPOTREBI KAO INHIBITORI STEAROIL-CoA-DESATURAZE | |
| JP2010506825A5 (enExample) | ||
| JP2006077019A5 (enExample) | ||
| JP2010540462A5 (enExample) | ||
| JP2010519181A5 (enExample) | ||
| WO2007043457A1 (ja) | トリアリールカルボン酸誘導体 | |
| JP2005517006A5 (enExample) | ||
| CA2645291A1 (en) | Dibenzyl amine derivatives as cetp inhibitors | |
| JP2010524899A5 (enExample) | ||
| US11919883B2 (en) | Metalloenzyme inhibitor compounds | |
| CA2617413A1 (en) | 2-aminoaryl pyridines as protein kinases inhibitors | |
| CA2410382A1 (en) | Heterocyclic compounds | |
| JP2000302680A (ja) | 脳保護剤 | |
| JPWO2001090087A1 (ja) | 複素環誘導体 | |
| JP2013542976A5 (enExample) |